Keryx Biopharmaceuticals : Termination of SUN-MACRO Phase 4 Trial

March 27, 2008 - Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced today that following a Drug Safety and Monitoring Committee (DSMC) review of the SUN-MACRO Phase 4 trial of Sulonex(TM) (sulodexide oral gelcap), the Company has decided to terminate the study and cease further development of Sulonex... Keryx's Press Release -

Keryx , Sulodexide Phase 3 study to continue without modification

Dec. 5, 2007 - Keryx Biopharmaceuticals (Nasdaq: KERX) announced that the Independent Data Safety Monitoring Committee (DSMC) responsible for monitoring Sulonex(TM) (sulodexide oral gelcaps), the Company's lead drug candidate under development as a treatment for diabetic nephropathy , recently met to evaluate the data from the ongoing Phase 3 trial... Keryx Biopharmaceuticals' Press Release -